CZ ATC L02BA01 · updated 2 Nov 2026
Tamoxifen shortage in Czechia
Is there a Tamoxifen shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Tamoxifen products are reported short in Czechia, the first since 16 Jun 2025. The company estimate for the return is 20 Nov 2026 (latest 15 Jul 2027). Main reason: manufacturing problem.
Also short in Canada, Austria, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TAMOXIFEN EBEWE 10MG 10MG TBL NOB 100 | EBEWE Pharma Ges.m.b.H Nfg.KG, Unterach | 16 Jun 2025 | 15 Jul 2027 | Manufacturing problem Výrobní důvody |
| CZ | TAMOXIFEN EBEWE 20MG 20MG TBL NOB 100 | EBEWE Pharma Ges.m.b.H Nfg.KG, Unterach | 8 Dec 2025 | 15 Jul 2027 | Manufacturing problem Výrobní důvody |
| CZ | TAMOXIFEN ORIFARM 20MG 20MG TBL NOB 100 | 8 Oct 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.